US2021038230A1PendingUtilityA1

Occlusive devices

Assignee: GORE & ASSPriority: Sep 16, 2011Filed: Aug 21, 2020Published: Feb 11, 2021
Est. expirySep 16, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61B 17/0057A61B 17/12145A61B 2017/00592A61B 2017/00632A61B 2017/00579A61B 2017/00597A61B 17/1215A61B 2017/00867A61B 2017/00641A61B 2017/00526A61B 17/12113A61B 2017/00243A61B 17/12122
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

An occlusive device includes a frame element having a distal end and a proximal end, and a delivery configuration and a deployed configuration. The occlusive device also includes an occlusive face having a peripheral edge, where the occlusive face positioned toward the proximal end of the frame element. The occlusive device also includes at least one anchor positioned at the peripheral edge of the occlusive face, where the at least one anchor extends at an acute angle to the peripheral edge of the occlusive face.

Claims

exact text as granted — not AI-modified
1 - 20 . (canceled) 
     
     
         21 . An occlusive device comprising:
 a proximal eyelet;   a distal eyelet;   a frame element having a longitudinal axis defined by a plurality of struts extending between the proximal eyelet and the distal eyelet;   a membrane attached to at least a portion of the frame element;   an occlusive face having a substantially concave orientation formed by the membrane and portions of the plurality of struts, the plurality of struts including curved portions extending away from the occlusive face toward the distal end;   a tapered region that extends between the distal end and the proximal end formed by other portions of the plurality of struts; and   a plurality of anchors arranged on the tapered region staggered relative to the longitudinal axis of the frame element and wherein at least a portion of at least one of the plurality of anchors protrudes through the membrane in a delivery configuration.   
     
     
         22 . The occlusive device of  claim 21 , wherein the occlusive face is configured to span a shape of an ostium in a deployed configuration. 
     
     
         23 . The occlusive device of  claim 21 , wherein at least one of the proximal eyelet and the distal eyelet are configured to attach to a delivery system. 
     
     
         24 . The occlusive device of  claim 21 , wherein the frame further includes a generally cylindrical region extending from the occlusive face in a distal direction, wherein the tapered region extends from the cylindrical region toward the distal end. 
     
     
         25 . The occlusive device of  claim 24 , wherein the plurality of anchors disposed near a junction of the cylindrical region and the tapered region. 
     
     
         26 . The occlusive device of  claim 21 , wherein each of the plurality of anchors includes a tissue engagement member that protrudes outwardly relative to the frame element. 
     
     
         27 . The occlusive device of  claim 21 , wherein the membrane covers at least a majority of the frame element. 
     
     
         28 . The occlusive device of  claim 21 , wherein the plurality of elongate members converge at the distal eyelet. 
     
     
         29 . The occlusive device of  claim 21 , wherein the frame element comprises nitinol. 
     
     
         30 . A system comprising:
 an occlusive device including a proximal eyelet, a distal eyelet, a frame element having a longitudinal axis defined by a plurality of struts extending between the proximal eyelet and the distal eyelet, a membrane attached to at least a portion of the frame element; an occlusive face having a substantially concave orientation formed by the membrane and portions of the plurality of struts, the plurality of struts including curved portions extending away from the occlusive face toward the distal end, a tapered region that extends between the distal end and the proximal end formed by other portions of the plurality of struts, and a plurality of anchors arranged on the tapered region staggered relative to the longitudinal axis of the frame element and protruding through the membrane; and   a delivery catheter configured to interface with at least one of the proximal eyelet and the distal eyelet and deploy the occlusive device.   
     
     
         31 . The system of  claim 30 , wherein the diameter of the occlusive face can be altered or adjusted during deployment of the occlusive device. 
     
     
         32 . The system of  claim 30 , wherein the occlusive face is configured to span a shape of an ostium in a deployed configuration. 
     
     
         33 . The system of  claim 30 , wherein at least one of the proximal eyelet and the distal eyelet are configured to attach to a delivery system. 
     
     
         34 . The system of  claim 33 , wherein the frame further includes a generally cylindrical region extending from the occlusive face in a distal direction, wherein the tapered region extends from the cylindrical region toward the distal end. 
     
     
         35 . The system of  claim 34 , wherein the plurality of anchors disposed near a junction of the cylindrical region and the tapered region.

Join the waitlist — get patent alerts

Track US2021038230A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.